+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dose-dependent cholesterol-lowering effects of phytosterol/phytostanol-enriched margarine in statin users and statin non-users under free-living conditions

Dose-dependent cholesterol-lowering effects of phytosterol/phytostanol-enriched margarine in statin users and statin non-users under free-living conditions

Public Health Nutrition 14(10): 1823-1832

To assess the effectiveness (extent to which an intervention works in daily medical practice) of the use of phytosterol/phytostanol-enriched margarines to lower total and non-HDL cholesterol levels in users and non-users of statins. Retrospective cohort study. Data were obtained from questionnaires on health and food intake from a population-based longitudinal cohort linked to pharmacy-dispensing records. The analysis included 3829 men and women (aged 31-71 years) who were examined during 1998-2002 and re-examined at 5-year follow-up during 2003-2007. Recommended doses of margarines were consumed by only 9 % of the subjects. Serum total cholesterol decreased by respectively -0·16 (95 % CI -0·26, -0·05) mmol/l, -1·40 (95 % CI -1·51, -1·30) mmol/l and -1·64 (95 % CI -1·91, -1·37) mmol/l in subjects who started to use phytosterols/phytostanols only, statins only or a combination of both compounds at some point in time between examination and re-examination, compared with subjects who did not start using phytosterols/phytostanols or statins. Cholesterol-lowering effects of the phytosterols/phytostanols were similar in statin users and statin non-users and increased with increasing intake of enriched margarine (no intake, 0; low intake, -0·017 (95 % CI -0·16, 0·13) mmol/l; medium intake, -0·089 (95 % CI -0·22, 0·038) mmol/l; high intake, -0·32 (95 % CI -0·50, -0·14) mmol/l). Although recommended intake levels of the enriched margarines were not reached by all persons, these data show that under customary conditions of use phytosterols/phytostanols are effective in lowering cholesterol levels in both statin users and non-users.

(PDF emailed within 0-6 h: $19.90)

Accession: 052704228

Download citation: RISBibTeXText

PMID: 21356148

DOI: 10.1017/S1368980011000164

Related references

Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction. European Heart Journal 33(13): 1582-1588, 2012

Heating Two Types of Enriched Margarine: Complementary Analysis of Phytosteryl/Phytostanyl Fatty Acid Esters and Phytosterol/Phytostanol Oxidation Products. Journal of Agricultural and Food Chemistry 64(13): 2699-2708, 2016

Peroxynitrite Footprint in Circulating Neutrophils of Abdominal Aortic Aneurysm Patients is Lower in Statin than in Non-statin Users. European Journal of Vascular and Endovascular Surgery 54(3): 331-339, 2017

Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users. Journal of Clinical Lipidology 6(3): 208-215, 2012

Outcome of Carotid Artery Endarterectomy in Statin Users versus Statin-Naïve Patients: A Systematic Review and Meta-Analysis. World Neurosurgery 116: 444-450.E1, 2018

Comparative meta-analysis of 6 statin and 9 non-statin coronary regression trials Evidence that cholesterol lowering is the key to outcomes. Circulation 94(8 SUPPL ): I579, 1996

Effects of the use of phytosterol/-stanol-enriched margarines on adherence to statin therapy. Pharmacoepidemiology and Drug Safety 19(12): 1225-1232, 2011

Niacin, fenofibrates increase benefits for statin users. These HDL- raising, triglyceride-lowering drugs beat out the use of additional LDL-lowering drugs. Dukemedicine Healthnews 16(8): 1-2, 2010

Television viewing time among statin users and non-users. The Polish Norwegian Study (PONS). Preventive Medicine Reports 7: 106-109, 2017

Genetically guided statin therapy on statin perceptions, adherence, and cholesterol lowering: a pilot implementation study in primary care patients. Journal of Personalized Medicine 4(2): 147-162, 2015

Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study. Nutrition, Metabolism, and Cardiovascular Diseases 25(11): 1016-1024, 2016

Periodontal status and hyperlipidemia: statin users versus non-users. Journal of Periodontology 84(1): 3-12, 2013

Combination regimens with statin, niacin, and intestinally active LDL-lowering drugs: alternatives to high-dose statin therapy?. Current Opinion in Lipidology 21(4): 372-377, 2010

Cholesterol-lowering food additives: lipase-catalysed preparation of phytosterol and phytostanol esters. Food Research International 35(2/3): 177-181, 2002

The food matrix and sterol characteristics affect the plasma cholesterol lowering of phytosterol/phytostanol. Advances in Nutrition 4(6): 633-643, 2014